<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Neuroscience</journal-id>
      <journal-title-group>
        <journal-title>Neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0306-4522</issn>
      <issn pub-type="epub">1873-7544</issn>
      <publisher>
        <publisher-name>Elsevier Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3092983</article-id>
      <article-id pub-id-type="pmid">21458543</article-id>
      <article-id pub-id-type="publisher-id">NSC12843</article-id>
      <article-id pub-id-type="doi">10.1016/j.neuroscience.2011.03.051</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Cognitive, Behavioral, and Systems Neuroscience</subject>
          <subj-group>
            <subject>Research Paper</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Altered GABA transmission in a mouse model of increased trait anxiety</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Tasan</surname>
            <given-names>R.O.</given-names>
          </name>
          <email>ramon.tasan@i-med.ac.at</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bukovac</surname>
            <given-names>A.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Peterschmitt</surname>
            <given-names>Y.N.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sartori</surname>
            <given-names>S.B.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Landgraf</surname>
            <given-names>R.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Singewald</surname>
            <given-names>N.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sperk</surname>
            <given-names>G.</given-names>
          </name>
          <email>guenther.sperk@i-med.ac.at</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Department of Pharmacology, Medical University Innsbruck, 6020 Innsbruck, Austria</aff>
      <aff id="aff2"><label>b</label>Center for Brain Research, Department of Biochemistry and Molecular Biology, Medical University Vienna, Vienna, Austria</aff>
      <aff id="aff3"><label>c</label>Department of Pharmacology and Toxicology, Institute of Pharmacy and Center of Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020 Innsbruck, Austria</aff>
      <aff id="aff4"><label>d</label>Max Planck Institute of Psychiatry, Behavioral Neuroendocrinology, Munich, Germany</aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding author. Tel: +0043-512-9003-71210 <email>ramon.tasan@i-med.ac.at</email><email>guenther.sperk@i-med.ac.at</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>02</day>
        <month>6</month>
        <year>2011</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <day>02</day>
        <month>6</month>
        <year>2011</year>
      </pub-date>
      <volume>183</volume>
      <issue>7</issue>
      <fpage>71</fpage>
      <lpage>80</lpage>
      <history>
        <date date-type="accepted">
          <day>24</day>
          <month>3</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2011 Elsevier Ltd.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>IBRO</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Anxiety disorders are the most prevalent central nervous system diseases imposing a high social burden to our society. Emotional processing is particularly controlled by GABA-ergic transmission in the amygdala. Using <bold><italic>in situ</italic></bold> hybridization and immunohistochemistry we now investigated changes in the expression of GABA synthesizing enzymes (GAD65 and GAD67), GABA<sub>A</sub> (α1–5, β1–3, γ1–2) and GABA<sub>B</sub> receptor subunits (GBBR1, GBBR2) in amygdaloid nuclei of high anxiety-related behavior (HAB) mice in comparison to mice selected for normal anxiety-related behavior (NAB). Levels of GAD65 and GAD67 mRNAs and protein, as well as those of GABA were increased in the amygdala of HAB mice. Relative to NAB controls, mRNA expression of the GABA<sub>A</sub> receptor subunits β1, β2 and γ2 was specifically increased in the basolateral amygdala of HAB mice while transcription of α5 and γ1 subunits was reduced in the central and medial amygdala. On the protein level, increases in β2 and γ2 subunit immunoreactivities were evident in the basolateral amygdala of HAB mice. No change in GABA<sub>B</sub> receptor expression was observed. These findings point towards an imbalanced GABA-ergic neurotransmission in the amygdala of HAB mice. On the other hand, FosB, a marker for neuronal activity, was increased in principal neurons of the basolateral amygdala in HAB mice, reflecting activation of excitatory neurons, possibly as a consequence of reduced GABA-ergic tonic inhibition through α5 and γ1 containing receptors. Ultimately these mechanisms may lead to the compensatory activation of GABA transmission, as indicated by the increased expression of GAD65/67 in HAB mice.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <sec>
          <title>Graphical Abstract</title>
          <p>
            <fig id="fig0005" position="anchor">
              <graphic xlink:href="gr1ab"/>
            </fig>
          </p>
        </sec>
        <sec>
          <title>Highlights</title>
          <p>▶Mice with increased trait anxiety revealed: ▶Increased activity of principal neurons of the basolateral amygdala. ▶A compensatory increase of glutamate decarboxylase expression. ▶Differential alterations of GABA<sub>A</sub> receptor subunit expression in the amygdala.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Key words</title>
        <kwd>GABA<sub>A</sub> receptor</kwd>
        <kwd>glutamate decarboxylase</kwd>
        <kwd>HAB</kwd>
        <kwd>high anxiety-related behavior</kwd>
        <kwd>amygdala</kwd>
        <kwd>FosB</kwd>
      </kwd-group>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>BLA, basolateral amygdala</kwd>
        <kwd>CEA, central amygdala</kwd>
        <kwd>EPM, elevated plus maze</kwd>
        <kwd>GAD65, glutamic acid decarboxylase of 65 kilo Dalton</kwd>
        <kwd>GAD67, glutamic acid decarboxylase of 67 kilo Dalton</kwd>
        <kwd>HAB, high anxiety-related behavior</kwd>
        <kwd>LAB, low anxiety-related behavior</kwd>
        <kwd>MEA, medial amygdala</kwd>
        <kwd>NAB, normal anxiety-related behavior</kwd>
        <kwd>ROD, relative optical density</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Anxiety disorders are the most prevalent disorders of the central nervous system imposing a high social burden to individuals as well as to the society (<xref rid="bib1" ref-type="bibr">Andlin-Sobocki et al., 2005</xref>). While physiological anxiety is essential for the survival under changing environmental conditions, persistent generalized anxiety or exaggerated inappropriate fear are pathological manifestations that severely reduce quality of life (<xref rid="bib2 bib37" ref-type="bibr">Belzung and Griebel, 2001; Norrholm and Ressler, 2009</xref>). Little is known, however, about the molecular mechanisms leading to anxiety-related conditions.</p>
    <p>There is considerable evidence indicating a role of altered GABA-ergic transmission in human anxiety disorders (<xref rid="bib28" ref-type="bibr">Millan, 2003</xref>). Thus, benzodiazepines acting through GABA<sub>A</sub> receptors are among the most widely prescribed anxiolytic drugs (<xref rid="bib35" ref-type="bibr">Nemeroff, 2003</xref>). Changes in GABA<sub>A</sub> receptors were observed in limbic brain areas of panic disorder patients by [<sup>14</sup>C]flumazenil positron emission tomography (<xref rid="bib13" ref-type="bibr">Hasler et al., 2008</xref>) and single nucleotide polymorphisms in the glutamate decarboxylase65 (GAD65) gene were associated with increased susceptibility to anxiety disorders (<xref rid="bib16" ref-type="bibr">Hettema et al., 2006</xref>).</p>
    <p>GABA released from axon terminals can act on two classes of receptors, GABA<sub>A</sub> and GABA<sub>B</sub> receptors. GABA<sub>A</sub> receptors are ligand-gated chloride channels (<xref rid="bib38" ref-type="bibr">Olsen and Sieghart, 2009</xref>) consisting of five subunits derived from more than 15 different genes. Most GABA<sub>A</sub> receptors, however, consist of two α-, two β- and one γ- or δ-subunit (<xref rid="bib48" ref-type="bibr">Sieghart and Sperk, 2002</xref>). The subunit composition determines the physiological and pharmacological properties of individual receptor subtypes. In particular α2- and γ2-subunits of the GABA<sub>A</sub> receptor have been implicated in mediating the anxiolytic effects of benzodiazepines (<xref rid="bib8 bib25 bib31" ref-type="bibr">Crestani et al., 1999; Low et al., 2000; Morris et al., 2006</xref>).</p>
    <p>GABA<sub>B</sub> receptors are G-protein coupled, inhibitory receptors that are generally formed by heteromeric assembly of two receptor molecules, one GABA<sub>B1</sub> (GBBR1) with a GABA<sub>B2</sub> (GBBR2) subunit (<xref rid="bib53" ref-type="bibr">Ulrich and Bettler, 2007</xref>). GABA<sub>B</sub> receptors may also play a role in the integration of anxiety, since mice deficient in GABA<sub>B</sub> receptors (GBBR1 or GBBR2) are more anxious in several behavioral paradigms (<xref rid="bib29 bib30" ref-type="bibr">Mombereau et al., 2004, 2005</xref>).</p>
    <p>The GABA-ergic system in the amygdala does not only modulate fear and anxiety under physiological conditions, but alterations in this system may also predispose individuals to pathological anxiety traits (<xref rid="bib47" ref-type="bibr">Shen et al., 2010</xref>). The aim of our present study was therefore to elucidate the role of the GABA-erigc system in anxiety-related behavior in HAB and NAB mouse lines. These two mouse lines expressing either high (HAB) or normal (NAB) levels of inborn anxiety-related behavior were selected by breeding according to their anxiety-related behavior displayed on the elevated plus maze (EPM) (<xref rid="bib20" ref-type="bibr">Kromer et al., 2005</xref>). The amygdala has a key role in the altered phenotypes of HAB mice, since mild emotional challenge of HAB mice results in differential activation of the amygdala and other brain areas (<xref rid="bib33" ref-type="bibr">Muigg et al., 2009</xref>). We performed <italic>in situ</italic> hybridization and immunohistochemistry for GABA synthesizing enzymes, glutamate decarboxylase 65 (GAD65) and 67 (GAD67), as well as for GABA<sub>A</sub> (α1–5, β1–3, γ1–2) and for GABA<sub>B</sub> (GBBR1, GBBR2) receptor subunits in the amygdala under conditions of chronically increased trait-anxiety of HAB compared to NAB mice.</p>
    <sec sec-type="methods" id="sec1">
      <title>Experimental procedures</title>
      <sec id="sec1.1">
        <title>Animals</title>
        <p>All procedures involving animals and animal care were conducted in accordance with international laws and policies (EEC Council Directive 86/609, OJ L 358, 1, December 12, 1987; Guide for the Care and Use of Laboratory Animals, U.S. National Research Council, 1996) and were approved by the Austrian Ministry of Science. All effort was taken to minimize the number of animals used and their suffering.</p>
        <p>Experiments were carried out on adult male HAB (<italic>n</italic>=20) and NAB (<italic>n</italic>=23) mice at 12–15 weeks of age bred in the animal facilities of the Department of Pharmacology and Toxicology, University of Innsbruck, Austria. As previously described in more detail (<xref rid="bib20 bib33" ref-type="bibr">Kromer et al., 2005; Muigg et al., 2009</xref>), the two lines were derived from a Swiss CD-1 outbred population selectively inbred for either high or normal anxiety-related behavior displayed on the EPM, with HAB mice spending less than 15% of the testing time on its open arms, compared with approximately 35% for NAB mice with no overlapping between the lines. The high anxiety phenotype of HAB mice was confirmed in the light/dark test and ultrasonic vocalization, previously (<xref rid="bib20" ref-type="bibr">Kromer et al., 2005</xref>). In the current experiments the behavioral phenotype of each mouse was tested by an EPM test at 7 weeks of age. Animals were housed under standard laboratory conditions (12:12 h light/dark cycle with lights on at 7:00) with food and water available <italic>ad libitum</italic>. Mice were housed in groups of four to five animals per cage.</p>
      </sec>
      <sec id="sec1.2">
        <title>Histochemistry</title>
        <sec id="sec1.2.1">
          <title>Tissue preparation</title>
          <p>In order to avoid detection of possible immediate changes of gene expression due to acute stress exposure of the mice during EPM testing, examination of the GABA-ergic system was performed 4 weeks after behavioral experiments. Mice were killed by carbon dioxide gas inhalation or by injecting an overdose of thiopental (Thiopental, Sandoz, Austria) for <italic>in situ</italic> hybridization and immunohistochemistry, respectively. Brains were either snap frozen (isopentane, −70 °C, 3 min) for <italic>in situ</italic> hybridization or perfused with 4% paraformaldehyde (PFA) for immunohistochemistry (<xref rid="bib50" ref-type="bibr">Tasan et al., 2010</xref>). Using a cryostat, coronal sections of 20 μm and 40 μm were cut for <italic>in situ</italic> hybridization and immunohistochemistry, respectively. Every seventh section was Nissl stained and series of matching sections were selected for subsequent histochemistry.</p>
        </sec>
        <sec id="sec1.2.2">
          <title>In situ hybridization</title>
          <p><italic>In situ</italic> hybridization was performed as described previously in detail (<xref rid="bib52 bib50" ref-type="bibr">Tsunashima et al., 1997; Tasan et al., 2010</xref>). Oligonucleotide probes targeting diverse markers of the GABA-ergic system are listed in <xref rid="tbl1" ref-type="table">Table 1</xref>. They were custom synthesized (Microsynth, Balgach, Switzerland, purified by HPLC). Oligonucleotides (2.5 pmol) were 3′ end-labeled by incubation with [<sup>35</sup>S]α-dATP (50 μCi; 1300 Ci/mmol, Hartmann Analytic GmbH, Braunschweig, Germany) and terminal transferase (Roche Diagnostics, Basel, Switzerland), as described previously in detail (<xref rid="bib52" ref-type="bibr">Tsunashima et al., 1997</xref>). Hybridization was performed in 50% formamide, 4× SSC (1× SSC is 150 mM NaCl, 15 mM sodium citrate, pH 7.2), 500 μg/ml salmon sperm DNA, 250 μg/ml yeast tRNA, 1× Denhardt's solution (0.02% Ficoll, 0.02% polyvinylpyrrolidone, and 0.02% bovine serum albumin), 10% dextran sulfate, and 20 mM dithiothreitol (all from Sigma) at 42 °C for 18 h. The slides were washed at stringent conditions (50% formamide in 2× SSC, 42 °C) and briefly rinsed in water followed by 70% ethanol, and dried. Slides were exposed to BioMax MR films (Amersham Pharmacia Biotech, Buckinghamshire, UK) together with [<sup>14</sup>C]-microscales for 7–14 days. For evaluation of the hybridization signal at the cellular level, some slides were dipped in Kodak NTB-2 photosensitive emulsion (Kodak, Rochester, NY, USA; diluted 1:1 with distilled water) at 42 °C, air dried over night, and then exposed for 4–6 weeks at 4 °C. The BioMax MR films and the dipped slides were developed with Kodak D19 developer. Sections were counterstained with Cresyl Violet, dehydrated, cleared in butyl acetate, and covered with a coverslip using Eukitt (Merck, Darmstadt, Germany).</p>
          <p>Quantitative evaluation of <italic>in situ</italic> hybridization was done using digitized images of the autoradiographs (eight bit digitized picture, 256 gray values). Gray values were measured by the public domain program ImageJ 1.38x (NIH, USA; 255=white; 0=black) and converted to relative optical density (ROD). ROD values obtained from autoradiographic images were plotted against standard curves obtained from images of [<sup>14</sup>C]-microscales exposed to the same film to insure that signal values are within the linear range of radioactivity, and then converted to percentage of control. Each value was obtained from the innermost 90% of the respective brain area. Adjacent background levels with no hybridization signal (internal capsule) were obtained separately for each brain section and side. The anatomical level was verified in sections counterstained with Cresyl Violet using a mouse brain atlas (<xref rid="bib11" ref-type="bibr">Franklin and Paxinos, 2007</xref>).</p>
        </sec>
        <sec id="sec1.2.3">
          <title>Immunohistochemistry</title>
          <p>Immunohistochemical analysis was performed on free-floating, PFA-fixed, 40 μm thick coronal sections using indirect peroxidase labeling, as described previously (<xref rid="bib12" ref-type="bibr">Furtinger et al., 2001</xref>). The following antisera were used: polyclonal rabbit anti-FosB (1:2000 SC-48; Santa Cruz Biotechnology), polyclonal rabbit anti-GABA (1:2000 A2052, Sigma), monoclonal mouse anti-GAD67 (1:15,000 MAB 5406; Chemicon), monoclonal mouse anti-CaMKII (1:5000 MAB, clone 6G9, Millipore), polyclonal rabbit anti-β2 subunit (1:100, residues 351–404) and polyclonal rabbit anti-γ2 subunit (1:300, residues 319–366) (both gifts from W. Sieghart, Vienna). A mouse Ig blocking reagent (VECTOR® M.O.M. immundetection kit, Vector laboratories, Inc., Burlingame, USA) was used for monoclonal mouse antibodies (GAD67, CaMKII). In brief, free floating coronal sections were incubated in 10% normal goat serum (Biomedica, Vienna, Austria) in Tris–HCl buffered saline (TBS; 50 mM, pH 7.2) for 90 min, followed by incubation with primary antiserum. The resulting complex was visualized by incubation with horseradish peroxidase-coupled secondary antibody (1:250 P0448; Dako, Vienna, Austria) at room temperature for 150 min. Sections were further incubated in a solution containing 0.03% 3,3′-diaminobenzidine tetrahydrochloride (Sigma, St. Louis, MO, USA) and 0.005% H<sub>2</sub>O<sub>2</sub> in TBS for 6 min. They were then mounted on slides, air-dried, dehydrated and coverslipped. After each incubation step (with the exception of preincubation with 10% normal goat serum), sections were washed three times for 5 min each with TBS. All buffers and antibody dilutions, except the buffer used for washing after peroxidase treatment and the diaminobenzidine reaction buffer, contained 0.4% Triton X-100. Normal goat serum (10%) was included in all buffers containing antibodies. In each experiment, sections without primary antibody were included as a control. No immuno-positive elements were detected in these control sections.</p>
          <p>In addition, dual labeling of FosB with either CaMKII as marker for pyramidal neurons or GAD67 as marker for non-pyramidal interneurons in the basolateral amygdala were performed to determine the type of FosB expressing neurons. Sections were incubated overnight at room temperature with rabbit anti-FosB antibody (1:500, SC-48; Santa Cruz Biotechnology) together with either a mouse monoclonal anti-CaMKII antibody (1:5000, Millipore, Billerica, MA, USA) or with a mouse monoclonal anti-GAD67 antibody (1:20,000, Chemicon, USA). Sections were rinsed in TBS-Triton (0.4%) and then incubated with a Vectastatin ABC-kit (Mouse IgG, Vector laboratories, Inc., Burlingame, USA) and donkey anti-rabbit Alexa Fluor 488 (1:500, Invitrogen, Eugene, USA) for 60 min at room temperature. After washing in TBS, sections were incubated in a tyramide amplification solution (1:100, TSA Plus Cyanine 3 System, PerkinElmer, MA, USA) for 2 min, mounted on slides and covered using Vectashield mounting medium (Vector laboratories, Inc., Burlingame, USA).</p>
          <p>Number of FosB, GAD67 and GABA immunoreactivity positive cells was obtained for each marker bilaterally from two matched sections per animal (four NAB and four HAB mice) in the basolateral amygdala (BLA) at a magnification of 400 times in multiple separate fields and mean values were calculated for each mouse. Results are presented as number of immunoreactivity positive cells/mm<sup>2</sup> and expressed as mean±SEM.</p>
          <p>Analysis of dual labeling immunofluorescence was done as described elsewhere (<xref rid="bib26" ref-type="bibr">McDonald and Mascagni, 2010</xref>). In brief, two matched sections per animal (four NAB and four HAB mice) containing the BLA were processed for either FosB/CaMK or FosB/GAD67 dual localization. Identification of dual labeled cells was performed at 400 times magnification in multiple separate fields within the BLA in each section.</p>
        </sec>
      </sec>
      <sec id="sec1.3">
        <title>Behavioral testing</title>
        <sec id="sec1.3.1">
          <title>Elevated plus maze</title>
          <p>This test was used as a widely accepted test for anxiety-like behavior as described in detail previously (<xref rid="bib24 bib51" ref-type="bibr">Lister, 1987; Tschenett et al., 2003</xref>).</p>
        </sec>
      </sec>
      <sec id="sec1.4">
        <title>Statistical analysis</title>
        <p>Data are presented as means±SEM. Data were analyzed for normal distribution and equal variances using GraphPad Prism software (Prism 5 for Macintosh, GraphPad Software Inc., San Diego, CA, USA). Statistical analysis of behavior was done by Student's <italic>t</italic>-test for data with normal distribution or Mann–Whitney test as a nonparametric test. ANOVA was used to analyze overall changes in percentage of mRNA ROD values in the CEA, BLA and MEA of HAB and NAB mice, with a Bonferroni <italic>post hoc</italic> test comparing HAB and NAB of the respective subregion. Linear regression and a Spearman correlation were used to investigate a correlation between mRNA expression and anxiety-related parameters as well as locomotor-related parameters on the EPM at 7 weeks of age.</p>
      </sec>
    </sec>
    <sec id="sec2">
      <title>Results</title>
      <p>HAB mice (<italic>n</italic>=20) showed a significantly reduced percentage of time spent in the open arms compared to NAB controls (<italic>n</italic>=23), (HAB: 5.2±0.89, NAB: 28.5±1.32, <italic>P</italic>&lt;0.0001) and percentage of open arm entries (HAB: 21.1±2.11, NAB: 44.5±1.65, <italic>P</italic>&lt;0.0001), indicating increased anxiety-related behavior and thus confirming the extremely anxious phenotype of each HAB mouse on the EPM. In addition, HAB mice exhibited reduced motor activity under stressful conditions as reflected by a decreased number of closed arm entries (HAB: 23.3±1.66, NAB: 33.9±1.53, <italic>P</italic>&lt;0.0001) and reduced total distance traveled (HAB: 9.1±0.82 m, NAB: 14.3±0.46 m, <italic>P</italic>&lt;0.0001) on the EPM during the 5 min testing period.</p>
      <sec id="sec2.1">
        <title>Histochemical results</title>
        <sec id="sec2.1.1">
          <title>Increased expression of GAD in the amygdala of HAB mice</title>
          <p>As shown in <xref rid="fig1" ref-type="fig">Fig. 1</xref>A, the mRNAs encoding for the GABA synthesizing enzymes GAD67 and GAD65 (not shown) were particularly concentrated in the central amygdala (CEA) while their expression was lower both in the medial (MEA) and basolateral nucleus of the amygdala (BLA). In HAB mice, a pronounced up-regulation of mRNA abundance of the GABA synthesizing enzymes GAD65 and GAD67 was evident in the amygdala (<xref rid="fig1" ref-type="fig">Fig. 1</xref>A, B, <xref rid="tbl2" ref-type="table">Table 2</xref>), but not in other brain regions, including the granule cell layer of the dentate gyrus in the dorsal (% of control NAB: 100.0±7.00 and HAB: 107.0±6.15; <italic>P</italic>=0.47, Student's <italic>t</italic>-test, mean±SEM) (<xref rid="fig1" ref-type="fig">Fig. 1</xref>A, C) as well as in the ventral hippocampus (% of control NAB: 100.0±6.07 and HAB: 85.4±7.09; <italic>P</italic>=0.14, Student's <italic>t</italic>-test, mean±SEM). To investigate whether the increased mRNA expression translates into higher protein levels we performed immunohistochemistry for GAD67 and GABA (<xref rid="fig2" ref-type="fig">Fig. 2</xref>). Indeed immunoreactivity for GAD67 (<xref rid="fig2" ref-type="fig">Fig. 2</xref>A, C) as well as for GABA (<xref rid="fig2" ref-type="fig">Fig. 2</xref>B, C) was enhanced in the amygdala of HAB mice.</p>
          <p>Since increased GAD67 mRNA expression may be caused by sustained neuronal activity due to chronically enhanced stress levels, we performed immunohistochemistry for ΔFosB, a marker of long-term adaptive changes in the brain. The number of FosB positive cells was significantly higher in the BLA of HAB mice than of NAB controls (<xref rid="fig3" ref-type="fig">Fig. 3</xref>A, B). In both, HAB and NAB mice, FosB labeling was co-localized with CaMKII labeling in the BLA (<xref rid="fig3" ref-type="fig">Fig. 3</xref>C), but was absent from GAD67 positive neurons (<xref rid="fig3" ref-type="fig">Fig. 3</xref>C), indicating chronic activation of principal neurons rather than of interneurons.</p>
        </sec>
        <sec id="sec2.1.2">
          <title>Expression of mRNA and immunoreactivity of GABA<sub>A</sub> and GABA<sub>B</sub> receptor subunits in the amygdala of NAB mice</title>
          <p>Control NAB mice revealed a similar distribution of GABA<sub>A</sub> receptor subunit mRNAs in the amygdaloid nuclei as previously described for C57BL/6J mice (<xref rid="bib14 bib15" ref-type="bibr">Heldt and Ressler, 2007a,b</xref>). High expression of GABA<sub>A</sub> receptor subunit α2, α3, β3 and γ2 mRNAs was observed in the BLA while GABA<sub>A</sub> receptor subunits α4 and β1 were moderately and α1, α5, β2 and γ1 subunit mRNAs only weakly expressed. In the CEA, there was a predominant expression of α2, α3, β3 and γ2 mRNAs and a moderate expression of β1 and γ1 subunit mRNAs. The MEA was characterized by high expression of GABA<sub>A</sub> receptor subunit α2, α3, β1, β3, γ1 and γ2 mRNAs. Regarding GABA<sub>B</sub> receptors, GBBR1 subunit mRNA was equally high expressed in the BLA, CEA and MEA, whereas the mRNA for the GBBR 2 subunit was restricted mainly to the BLA and MEA.</p>
        </sec>
        <sec id="sec2.1.3">
          <title>Altered expression of GABA<sub>A</sub> receptor subunits in the amygdala of HAB mice</title>
          <p>The expression profile of the different GABA<sub>A</sub> receptor subunit mRNAs in the amygdala of HAB mice was distinct from NAB controls. In HAB mice, there was a significant increase of GABA<sub>A</sub> receptor subunit β1 mRNA in all amygdala nuclei investigated (<xref rid="tbl2" ref-type="table">Table 2</xref>). In addition, the percentage of β2 mRNA was higher in the BLA, but not in the CEA or MEA of HAB mice (<xref rid="fig4" ref-type="fig">Fig. 4</xref>E–H, <xref rid="tbl2" ref-type="table">Table 2</xref>). Among the α-subunits only expression of α5 mRNA was altered in the amygdala. Although basal levels of α5 mRNA were already low throughout the amygdala of NAB controls, they were further reduced in the CEA and MEA of HAB mice (<xref rid="tbl2" ref-type="table">Table 2</xref>). Interestingly, in HAB mice the γ1 mRNA levels were reduced in all amygdaloid nuclei (<xref rid="fig4" ref-type="fig">Fig. 4</xref>A–D, <xref rid="tbl2" ref-type="table">Table 2</xref>), whereas those of γ2 mRNA were specifically increased in the BLA and CEA (<xref rid="tbl2" ref-type="table">Table 2</xref>). As shown in <xref rid="fig5" ref-type="fig">Fig. 5</xref>, β2 and γ2 subunit immunoreactivities were also clearly increased in the BLA of HAB mice.</p>
          <p>No difference in the mRNA abundance of both GABA<sub>B</sub> receptor subunits GBBR1 and GBBR2 was detected in any of the amygdaloid nuclei of HAB mice compared to NAB controls.</p>
        </sec>
        <sec id="sec2.1.4">
          <title>Correlation of GAD expression in the amygdala with EPM behavior</title>
          <p>To investigate whether increased expression of GADs may be associated with altered anxiety-like and/or locomotor-related behavior, we performed a correlational analysis of GAD67 and GAD65 mRNA levels with the behavioral data obtained from the EPM (percentage open arm time and total distance traveled). Indeed, the expression of GAD67 mRNA in the BLA of HAB mice, was <italic>positively</italic> correlated with the percentage of open arm time (<italic>r</italic>=0.58, <italic>P</italic>=0.019; <xref rid="fig1" ref-type="fig">Fig. 1</xref>D), but not with the total distance traveled by the mice (<italic>r</italic>=0.40, <italic>P</italic>=0.139). In contrast, no correlation of GAD67 mRNA levels with percentage open arm time (<italic>r</italic>=0.21, <italic>P</italic>=0.383; <xref rid="fig1" ref-type="fig">Fig. 1</xref>E) or total distance traveled (<italic>r</italic>=−0.005, <italic>P</italic>=0.983) was observed in NAB mice. These findings imply that the up-regulation of the GAD67 may be a compensatory reaction to the high anxiety behavior phenotype of HAB mice. In contrast, when we included both groups, HAB and NAB mice, into the analysis there was a negative correlation of GAD65 and GAD67 mRNAs expression in all amygdaloid nuclei (BLA, CEA and MEA) with both, anxiety-like and locomotor-related behavior on the EPM (data not shown). These findings were not surprising, since they reflect largely the differences in the preselected phenotypes.</p>
          <p>Altered GABA<sub>A</sub> receptor subunit mRNA expression correlated with anxiety- and motor activity-related behavior when both groups, HAB and NAB mice, were included. There was no correlation, however, at the level of the individual groups (not shown).</p>
        </sec>
      </sec>
    </sec>
    <sec id="sec3">
      <title>Discussion</title>
      <p>The present study identified prominent changes of the GABA system in the amygdala of HAB mice, an animal model of increased trait anxiety. These include markedly increased expression of the GABA synthesizing enzymes GAD65 and GAD67 together with increased expression of GABA<sub>A</sub> receptor subunit β1, β2, γ2 mRNAs, whereas subunit α5 and γ1 mRNA levels were decreased.</p>
      <p>In the BLA, most non-pyramidal neurons use GABA as a principal neurotransmitter and exert an inhibitory action on glutamatergic principal cells (<xref rid="bib39" ref-type="bibr">Pare et al., 2003</xref>). This inhibition is predominantly generated through GABA<sub>A</sub> receptors that mediate either a phasic response when located within the synapse or maintain tonic inhibition at extrasynaptic sites (<xref rid="bib44 bib45" ref-type="bibr">Semyanov et al., 2003, 2004</xref>). Spontaneous firing rates in the lateral and central amygdala are among the lowest in the brain, indicating potent tonic inhibition suppressing neuronal activity in the amygdala (<xref rid="bib41" ref-type="bibr">Quirk and Gehlert, 2003</xref>). On the other hand, repeated stimulation of the BLA, leads to long-term synaptic facilitation and a behavioral state of chronic anxiety (<xref rid="bib42" ref-type="bibr">Sajdyk and Shekhar, 2000</xref>).</p>
      <sec id="sec3.1">
        <title>GABA synthesizing enzymes (GAD65 and GAD67)</title>
        <p>GAD65 and GAD67 are catalyzing GABA synthesis and their activity is tightly related to the tone of GABA neurons. They are abundantly expressed in the amygdala (<xref rid="fig1" ref-type="fig">Fig. 1</xref>A). In the BLA both enzymes are primarily expressed in interneurons (<xref rid="bib27" ref-type="bibr">McDonald and Pearson, 1989</xref>) whereas in the CEA they are also contained in GABA-ergic projection neurons targeting forebrain and brain stem areas (<xref rid="bib21 bib4" ref-type="bibr">LeDoux et al., 1988; Bourgeais et al., 2001</xref>). Impaired GABA-ergic transmission in GAD65 knockout mice results in increased anxiety-related behavior in the open field and elevated zero maze (<xref rid="bib18" ref-type="bibr">Kash et al., 1999</xref>). Considerable evidence suggests that increased GABA-ergic transmission in the BLA is associated with reduced anxiety, while increasing the excitability of BLA projection neurons by inhibition of GABA transmission tends to be anxiogenic (<xref rid="bib9 bib46" ref-type="bibr">Davis et al., 1994; Shekhar et al., 2003</xref>). In contrast, the high anxiety level in HAB mice is associated with an increased expression of GAD65 and GAD67. This increase in GABA synthesis may be part of a compensatory mechanism balancing the persistent over-stimulation of limbic brain areas, as indicated by the positive correlation of GAD mRNA expression with percentage open arm time. The increased expression of GADs may be driven by a sustained activation of the amygdala in HAB mice. On the other hand recent evidence suggests also excitatory actions of GABA in the basal amygdala (<xref rid="bib54" ref-type="bibr">Woodruff et al., 2006</xref>), resulting in rapid activation of basolateral pyramidal neurons that may significantly contribute to increased anxiety-related behavior.</p>
        <p>Activation of amygdala nuclei in response to stress has been well documented by increased expression of immediate early genes c-Fos and Zif-268 (<xref rid="bib17 bib49 bib19" ref-type="bibr">Hoffman and Lyo, 2002; Singewald, 2007; Kovacs, 2008</xref>) and has also been demonstrated in limbic areas of HAB mice (<xref rid="bib33" ref-type="bibr">Muigg et al., 2009</xref>). Recently, <xref rid="bib5" ref-type="bibr">Carta et al. (2008)</xref> reported increased expression of GAD67 mRNA in the CEA in response to stressful stimuli, reflecting long-term changes in neuronal activity (<xref rid="bib5" ref-type="bibr">Carta et al., 2008</xref>). In the present study, the pronounced increases of GAD65 and GAD67 mRNAs in the amygdala of HAB mice may reflect chronic activation in amygdala nuclei due to consistently higher stress levels in these mice. This is supported by the increase in FosB-positive principal (glutamatergic) neurons in the BLA of HAB mice indicating chronic activation of the amygdala in the highly anxious HAB line already under baseline, non-stressful conditions.</p>
        <p>This idea is further supported by a study in rats demonstrating that low exploratory activity on the EPM is associated with increased expression of GAD65/67 mRNA in the amygdala (<xref rid="bib34" ref-type="bibr">Nelovkov et al., 2006</xref>). Notably, low exploratory behavior, besides reduced general motor activity may be related to increased anxiety, particularly when displayed in stressful situations like EPM exposure (<xref rid="bib34" ref-type="bibr">Nelovkov et al., 2006</xref>). Our correlation analysis revealed lower anxiety in HAB mice correlating with high GAD67 mRNA levels (<xref rid="fig1" ref-type="fig">Fig. 1</xref>D). While this correlation provides informative evidence, further experiments, however, are needed to obtain a clear causal relationship between an altered GABA-ergic system and anxiety-related behavior in these mice.</p>
      </sec>
      <sec id="sec3.2">
        <title>GABA<sub>A</sub> receptor α subunits</title>
        <p>Receptors containing the α5 subunit are often located extrasynaptically, predominantly mediating tonic inhibition (<xref rid="bib43 bib55" ref-type="bibr">Scimemi et al., 2005; Zarnowska et al., 2009</xref>). Mice with reduced expression of α5 subunit in the hippocampus display facilitated trace fear conditioning, a special form of associative learning that requires hippocampal processing (<xref rid="bib7" ref-type="bibr">Crestani et al., 2002</xref>). Although most of the investigations on α5 subunits have been performed in the hippocampus, a similar yet more anxiety-related role may be integrated in the amygdala. Since HAB mice displayed a decreased abundance of α5 subunit mRNAs in the CEA and MEA, a reduced inhibitory tonus in the amygdala of HAB mice may facilitate emotional activation and propagate a behavioral state of enhanced trait anxiety. Indeed, over-excitation after mild emotional challenge has been demonstrated recently in the amygdala of HAB compared to NAB mice (<xref rid="bib33" ref-type="bibr">Muigg et al., 2009</xref>).</p>
      </sec>
      <sec id="sec3.3">
        <title>GABA<sub>A</sub> receptor β subunits</title>
        <p>Given that β subunits contain part of the binding pocket for GABA, any change in their expression level is of physiological significance. <italic>In situ</italic> hybridization experiments indicate an increase of β1 subunit mRNA in all amygdaloid nuclei investigated (BLA, CEA and MEA) and a selective increase of β2 mRNA restricted to the BLA of HAB mice (<xref rid="tbl2" ref-type="table">Table 2</xref>). Recently, <xref rid="bib14" ref-type="bibr">Heldt et al. (2007a)</xref> demonstrated an up-regulation of β2 subunit in the amygdala after fear conditioning in mice after unpaired tone-shock exposure. They speculated that this reflected a state of hyperexcitability, similar to increased expression levels of β subunits seen in seizure-evoked animal models of epilepsy (<xref rid="bib52 bib40 bib36" ref-type="bibr">Tsunashima et al., 1997; Pirker et al., 2003; Nishimura et al., 2005</xref>). Therefore also in HAB mice the selective increase in β2 subunit mRNA may be due to over-excitation of the BLA as indicated by increased number of FosB positive neurons under baseline conditions.</p>
      </sec>
      <sec id="sec3.4">
        <title>GABA<sub>A</sub> receptor γ subunits</title>
        <p>In HAB mice, we observed a reduction of the γ1 subunit mRNA levels in all amygdaloid nuclei investigated (<xref rid="tbl2" ref-type="table">Table 2</xref>), whereas those of the γ2 subunit were increased specifically in the BLA and CEA (<xref rid="tbl2" ref-type="table">Table 2</xref>). The mRNA levels for the δ subunit were below detection limit in the amygdala. The γ2 subunit mediates postsynaptic clustering and is required for normal channel functioning (<xref rid="bib8" ref-type="bibr">Crestani et al., 1999</xref>). Knockout mice, heterozygous for the γ2 subunit, display increased anxiety-related behavior and reduced benzodiazepine binding sites. Although the total number of GABA<sub>A</sub> receptors is not altered, synaptic clustering is significantly reduced (<xref rid="bib8" ref-type="bibr">Crestani et al., 1999</xref>). The increased expression of the γ2 subunit mRNA in HAB mice may reflect an accelerated turnover of the γ2 subunit containing GABA<sub>A</sub> receptors due to chronically high stress conditions and may indicate a compensatory mechanism counteracting increased amygdala activity. Following EPM exposure, <xref rid="bib6" ref-type="bibr">Chacur et al. (1999)</xref> observed increased [<sup>3</sup>H]-flunitrazepam but not [<sup>3</sup>H]-muscimol binding specifically in the CEA and BLA, indicating a higher sensitivity of GABA<sub>A</sub> receptors to benzodiazepines although the total number of receptors may not be altered (<xref rid="bib6" ref-type="bibr">Chacur et al., 1999</xref>).</p>
        <p>Increased sensitivity to the anxiolytic effect of diazepam is generally observed in rodents with low explorative activity and changes in the subunit composition of GABA<sub>A</sub> receptors due to altered subunit expression may be an attractive explanation for this phenomenon (<xref rid="bib22 bib3 bib34" ref-type="bibr">Liebsch et al., 1998; Bert et al., 2001; Nelovkov et al., 2006</xref>). In the present study, also HAB mice exhibit low explorative activity during EPM stress, presumably related to the high trait anxiety of these mice. Thus, the high sensitivity of HAB mice to the anxiolytic effect of benzodiazepines (<xref rid="bib20" ref-type="bibr">Kromer et al., 2005</xref>) may, at least in part, be related to the higher number of γ2 containing GABA<sub>A</sub> receptors, known to mediate the action of benzodiazepines in the amygdala.</p>
        <p>Interestingly, whereas γ2 subunits are increased in the amygdala of HAB mice, γ1 subunits, particularly enriched in the CEA and MEA, are significantly reduced in these mice (<xref rid="tbl2" ref-type="table">Table 2</xref>). <xref rid="bib10" ref-type="bibr">Esmaeili et al. (2009)</xref> recently demonstrated that GABA-ergic synapses formed by lateral inputs to the CEA, probably originating from intercalated cell masses, contain γ1 subunits (<xref rid="bib10" ref-type="bibr">Esmaeili et al., 2009</xref>). These connections are important for extinction of conditioned fear (<xref rid="bib23" ref-type="bibr">Likhtik et al., 2008</xref>). Deficits in extinction learning have been described for HAB rats (<xref rid="bib32" ref-type="bibr">Muigg et al., 2008</xref>) and mice (Yen et al., unpublished observation) and could be associated with decreased γ1 subunit expression.</p>
      </sec>
    </sec>
    <sec id="sec4">
      <title>Conclusion</title>
      <p>We demonstrated differential alterations of the GABA-ergic system in the amygdala of HAB mice, a model of pathological trait anxiety. Expression of GAD65 and GAD67 was highly up-regulated on mRNA as well as on protein level, suggesting enhanced GABA synthesis and release. Notably the increases in GAD65/67 and γ2 subunit expression, but also that of subunits β1 and β2, point towards a facilitated GABA transmission, aiming to compensate the high-anxiety state of HAB mice. On the other hand, the reduced expression of the α5 subunit in the CEA and MEA may be part of the molecular mechanisms leading to the anxious phenotype of HAB mice. A reduced number of α5 subunit containing receptors may cause reduced tonic inhibition, favoring activation of the amygdala even under non-stressful conditions as illustrated by the increase in FosB expression. Both mechanisms may be causatively related to the compensatory increase in GAD65 and GAD67 expression.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andlin-Sobocki</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Jonsson</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Wittchen</surname>
              <given-names>H.U.</given-names>
            </name>
            <name>
              <surname>Olesen</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Cost of disorders of the brain in Europe</article-title>
          <source>Eur J Neurol</source>
          <volume>12</volume>
          <issue>Suppl 1</issue>
          <year>2005</year>
          <fpage>1</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">15877774</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belzung</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Griebel</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Measuring normal and pathological anxiety-like behaviour in mice: a review</article-title>
          <source>Behav Brain Res</source>
          <volume>125</volume>
          <year>2001</year>
          <fpage>141</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="pmid">11682105</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bert</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sohr</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Rex</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Different effects of diazepam in Fischer rats and two stocks of Wistar rats in tests of anxiety</article-title>
          <source>Pharmacol Biochem Behav</source>
          <volume>70</volume>
          <year>2001</year>
          <fpage>411</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="pmid">11701214</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bourgeais</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Gauriau</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bernard</surname>
              <given-names>J.F.</given-names>
            </name>
          </person-group>
          <article-title>Projections from the nociceptive area of the central nucleus of the amygdala to the forebrain: a PHA-L study in the rat</article-title>
          <source>Eur J Neurosci</source>
          <volume>14</volume>
          <year>2001</year>
          <fpage>229</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="pmid">11553276</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carta</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Cadoni</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Tronci</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Di Chiara</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress</article-title>
          <source>Eur J Neurosci</source>
          <volume>27</volume>
          <year>2008</year>
          <fpage>1220</fpage>
          <lpage>1230</lpage>
          <pub-id pub-id-type="pmid">18312583</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chacur</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Raymond</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hipolide</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Giugliano</surname>
              <given-names>E.B.</given-names>
            </name>
            <name>
              <surname>Leite</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Nobrega</surname>
              <given-names>J.N.</given-names>
            </name>
          </person-group>
          <article-title>Immediate increase in benzodiazepine binding in rat brain after a single brief experience in the plus maze: a paradoxical effect</article-title>
          <source>Neurosci Lett</source>
          <volume>269</volume>
          <year>1999</year>
          <fpage>29</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">10821637</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crestani</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Keist</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Fritschy</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Benke</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Vogt</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Prut</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bluthmann</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Mohler</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rudolph</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <volume>99</volume>
          <year>2002</year>
          <fpage>8980</fpage>
          <lpage>8985</lpage>
          <pub-id pub-id-type="pmid">12084936</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crestani</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Lorez</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Baer</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Essrich</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Benke</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Laurent</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Belzung</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Fritschy</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Luscher</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Mohler</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues</article-title>
          <source>Nat Neurosci</source>
          <volume>2</volume>
          <year>1999</year>
          <fpage>833</fpage>
          <lpage>839</lpage>
          <pub-id pub-id-type="pmid">10461223</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Rainnie</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Cassell</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Neurotransmission in the rat amygdala related to fear and anxiety</article-title>
          <source>Trends Neurosci</source>
          <volume>17</volume>
          <year>1994</year>
          <fpage>208</fpage>
          <lpage>214</lpage>
          <pub-id pub-id-type="pmid">7520203</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Esmaeili</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Sah</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>GABAA receptors containing gamma1 subunits contribute to inhibitory transmission in the central amygdala</article-title>
          <source>J Neurophysiol</source>
          <volume>101</volume>
          <year>2009</year>
          <fpage>341</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="pmid">19004994</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <mixed-citation publication-type="other">Franklin KBJ, Paxinos G (2007) The mouse brain in stereotaxic coordinates, 3rd edition. London: Elsevier.</mixed-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furtinger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Pirker</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Czech</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Baumgartner</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ransmayr</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Sperk</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy</article-title>
          <source>J Neurosci</source>
          <volume>21</volume>
          <year>2001</year>
          <fpage>5804</fpage>
          <lpage>5812</lpage>
          <pub-id pub-id-type="pmid">11466452</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hasler</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Nugent</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Carson</surname>
              <given-names>R.E.</given-names>
            </name>
            <name>
              <surname>Geraci</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Drevets</surname>
              <given-names>W.C.</given-names>
            </name>
          </person-group>
          <article-title>Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography</article-title>
          <source>Arch Gen Psychiatry</source>
          <volume>65</volume>
          <year>2008</year>
          <fpage>1166</fpage>
          <lpage>1175</lpage>
          <pub-id pub-id-type="pmid">18838633</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heldt</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Ressler</surname>
              <given-names>K.J.</given-names>
            </name>
          </person-group>
          <article-title>Training-induced changes in the expression of GABAA-associated genes in the amygdala after the acquisition and extinction of Pavlovian fear</article-title>
          <source>Eur J Neurosci</source>
          <volume>26</volume>
          <year>2007</year>
          <fpage>3631</fpage>
          <lpage>3644</lpage>
          <pub-id pub-id-type="pmid">18088283</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heldt</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Ressler</surname>
              <given-names>K.J.</given-names>
            </name>
          </person-group>
          <article-title>Forebrain and midbrain distribution of major benzodiazepine-sensitive GABAA receptor subunits in the adult C57 mouse as assessed with <italic>in situ</italic> hybridization</article-title>
          <source>Neuroscience</source>
          <volume>150</volume>
          <year>2007</year>
          <fpage>370</fpage>
          <lpage>385</lpage>
          <pub-id pub-id-type="pmid">17950542</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hettema</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>An</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Neale</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Bukszar</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>van den Oord</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Kendler</surname>
              <given-names>K.S.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism</article-title>
          <source>Mol Psychiatry</source>
          <volume>11</volume>
          <year>2006</year>
          <fpage>752</fpage>
          <lpage>762</lpage>
          <pub-id pub-id-type="pmid">16718280</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoffman</surname>
              <given-names>G.E.</given-names>
            </name>
            <name>
              <surname>Lyo</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Anatomical markers of activity in neuroendocrine systems: are we all “fos-ed out”?</article-title>
          <source>J Neuroendocrinol</source>
          <volume>14</volume>
          <year>2002</year>
          <fpage>259</fpage>
          <lpage>268</lpage>
          <pub-id pub-id-type="pmid">11963822</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kash</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Tecott</surname>
              <given-names>L.H.</given-names>
            </name>
            <name>
              <surname>Hodge</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Baekkeskov</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <volume>96</volume>
          <year>1999</year>
          <fpage>1698</fpage>
          <lpage>1703</lpage>
          <pub-id pub-id-type="pmid">9990087</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kovacs</surname>
              <given-names>K.J.</given-names>
            </name>
          </person-group>
          <article-title>Measurement of immediate-early gene activation- c-fos and beyond</article-title>
          <source>J Neuroendocrinol</source>
          <volume>20</volume>
          <year>2008</year>
          <fpage>665</fpage>
          <lpage>672</lpage>
          <pub-id pub-id-type="pmid">18601687</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kromer</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Kessler</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Milfay</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Birg</surname>
              <given-names>I.N.</given-names>
            </name>
            <name>
              <surname>Bunck</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Czibere</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Panhuysen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Putz</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Deussing</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Holsboer</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Landgraf</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Turck</surname>
              <given-names>C.W.</given-names>
            </name>
          </person-group>
          <article-title>Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety</article-title>
          <source>J Neurosci</source>
          <volume>25</volume>
          <year>2005</year>
          <fpage>4375</fpage>
          <lpage>4384</lpage>
          <pub-id pub-id-type="pmid">15858064</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>LeDoux</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Iwata</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Cicchetti</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>D.J.</given-names>
            </name>
          </person-group>
          <article-title>Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear</article-title>
          <source>J Neurosci</source>
          <volume>8</volume>
          <year>1988</year>
          <fpage>2517</fpage>
          <lpage>2529</lpage>
          <pub-id pub-id-type="pmid">2854842</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liebsch</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Linthorst</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Neumann</surname>
              <given-names>I.D.</given-names>
            </name>
            <name>
              <surname>Reul</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Holsboer</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Landgraf</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior</article-title>
          <source>Neuropsychopharmacology</source>
          <volume>19</volume>
          <year>1998</year>
          <fpage>381</fpage>
          <lpage>396</lpage>
          <pub-id pub-id-type="pmid">9778660</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Likhtik</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Popa</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Apergis-Schoute</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Fidacaro</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Pare</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Amygdala intercalated neurons are required for expression of fear extinction</article-title>
          <source>Nature</source>
          <volume>454</volume>
          <year>2008</year>
          <fpage>642</fpage>
          <lpage>645</lpage>
          <pub-id pub-id-type="pmid">18615014</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lister</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>The use of a plus-maze to measure anxiety in the mouse</article-title>
          <source>Psychopharmacology (Berl)</source>
          <volume>92</volume>
          <year>1987</year>
          <fpage>180</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="pmid">3110839</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Low</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Crestani</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Keist</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Benke</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Brunig</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Benson</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Fritschy</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Rulicke</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bluethmann</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Mohler</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rudolph</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>Molecular and neuronal substrate for the selective attenuation of anxiety</article-title>
          <source>Science</source>
          <volume>290</volume>
          <year>2000</year>
          <fpage>131</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="pmid">11021797</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McDonald</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Mascagni</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Neuronal localization of m1 muscarinic receptor immunoreactivity in the rat basolateral amygdala</article-title>
          <source>Brain Struct Funct</source>
          <volume>215</volume>
          <year>2010</year>
          <fpage>37</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="pmid">20503057</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McDonald</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala</article-title>
          <source>Neurosci Lett</source>
          <volume>100</volume>
          <year>1989</year>
          <fpage>53</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">2569703</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Millan</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>The neurobiology and control of anxious states</article-title>
          <source>Prog Neurobiol</source>
          <volume>70</volume>
          <year>2003</year>
          <fpage>83</fpage>
          <lpage>244</lpage>
          <pub-id pub-id-type="pmid">12927745</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mombereau</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kaupmann</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Froestl</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Sansig</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>van der Putten</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Cryan</surname>
              <given-names>J.F.</given-names>
            </name>
          </person-group>
          <article-title>Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior</article-title>
          <source>Neuropsychopharmacology</source>
          <volume>29</volume>
          <year>2004</year>
          <fpage>1050</fpage>
          <lpage>1062</lpage>
          <pub-id pub-id-type="pmid">15039762</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mombereau</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kaupmann</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gassmann</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bettler</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>van der Putten</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Cryan</surname>
              <given-names>J.F.</given-names>
            </name>
          </person-group>
          <article-title>Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits</article-title>
          <source>Neuroreport</source>
          <volume>16</volume>
          <year>2005</year>
          <fpage>307</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="pmid">15706241</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morris</surname>
              <given-names>H.V.</given-names>
            </name>
            <name>
              <surname>Dawson</surname>
              <given-names>G.R.</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Atack</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Stephens</surname>
              <given-names>D.N.</given-names>
            </name>
          </person-group>
          <article-title>Both alpha2 and alpha3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm</article-title>
          <source>Eur J Neurosci</source>
          <volume>23</volume>
          <year>2006</year>
          <fpage>2495</fpage>
          <lpage>2504</lpage>
          <pub-id pub-id-type="pmid">16706856</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muigg</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hetzenauer</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hauer</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hauschild</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gaburro</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Frank</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Landgraf</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Singewald</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Impaired extinction of learned fear in rats selectively bred for high anxiety—evidence of altered neuronal processing in prefrontal-amygdala pathways</article-title>
          <source>Eur J Neurosci</source>
          <volume>28</volume>
          <year>2008</year>
          <fpage>2299</fpage>
          <lpage>2309</lpage>
          <pub-id pub-id-type="pmid">19019199</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muigg</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Scheiber</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Salchner</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bunck</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Landgraf</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Singewald</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Differential stress-induced neuronal activation patterns in mouse lines selectively bred for high, normal or low anxiety</article-title>
          <source>PLoS One</source>
          <volume>4</volume>
          <year>2009</year>
          <fpage>e5346</fpage>
          <pub-id pub-id-type="pmid">19399175</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nelovkov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Areda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Innos</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Koks</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vasar</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Rats displaying distinct exploratory activity also have different expression patterns of gamma-aminobutyric acid- and cholecystokinin-related genes in brain regions</article-title>
          <source>Brain Res</source>
          <volume>1100</volume>
          <year>2006</year>
          <fpage>21</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">16769038</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nemeroff</surname>
              <given-names>C.B.</given-names>
            </name>
          </person-group>
          <article-title>The role of GABA in the pathophysiology and treatment of anxiety disorders</article-title>
          <source>Psychopharmacol Bull</source>
          <volume>37</volume>
          <year>2003</year>
          <fpage>133</fpage>
          <lpage>146</lpage>
          <pub-id pub-id-type="pmid">15131523</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishimura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Schwarzer</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Gasser</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Vezzani</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sperk</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Altered expression of GABA(A) and GABA(B) receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus</article-title>
          <source>Neuroscience</source>
          <volume>134</volume>
          <year>2005</year>
          <fpage>691</fpage>
          <lpage>704</lpage>
          <pub-id pub-id-type="pmid">15951123</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Norrholm</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Ressler</surname>
              <given-names>K.J.</given-names>
            </name>
          </person-group>
          <article-title>Genetics of anxiety and trauma-related disorders</article-title>
          <source>Neuroscience</source>
          <volume>164</volume>
          <year>2009</year>
          <fpage>272</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="pmid">19540311</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olsen</surname>
              <given-names>R.W.</given-names>
            </name>
            <name>
              <surname>Sieghart</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>GABA A receptors: subtypes provide diversity of function and pharmacology</article-title>
          <source>Neuropharmacology</source>
          <volume>56</volume>
          <year>2009</year>
          <fpage>141</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="pmid">18760291</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pare</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Royer</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>E.J.</given-names>
            </name>
          </person-group>
          <article-title>Contextual inhibitory gating of impulse traffic in the intra-amygdaloid network</article-title>
          <source>Ann N Y Acad Sci</source>
          <volume>985</volume>
          <year>2003</year>
          <fpage>78</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">12724150</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pirker</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Schwarzer</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Czech</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Baumgartner</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pockberger</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Maier</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hauer</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Sieghart</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Furtinger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sperk</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Increased expression of GABA(A) receptor beta-subunits in the hippocampus of patients with temporal lobe epilepsy</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <volume>62</volume>
          <year>2003</year>
          <fpage>820</fpage>
          <lpage>834</lpage>
          <pub-id pub-id-type="pmid">14503638</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quirk</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Gehlert</surname>
              <given-names>D.R.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of the amygdala: key to pathological states?</article-title>
          <source>Ann N Y Acad Sci</source>
          <volume>985</volume>
          <year>2003</year>
          <fpage>263</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="pmid">12724164</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sajdyk</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Shekhar</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Sodium lactate elicits anxiety in rats after repeated GABA receptor blockade in the basolateral amygdala</article-title>
          <source>Eur J Pharmacol</source>
          <volume>394</volume>
          <year>2000</year>
          <fpage>265</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="pmid">10771292</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scimemi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Semyanov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sperk</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kullmann</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>M.C.</given-names>
            </name>
          </person-group>
          <article-title>Multiple and plastic receptors mediate tonic GABAA receptor currents in the hippocampus</article-title>
          <source>J Neurosci</source>
          <volume>25</volume>
          <year>2005</year>
          <fpage>10016</fpage>
          <lpage>10024</lpage>
          <pub-id pub-id-type="pmid">16251450</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Semyanov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Kullmann</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>GABA uptake regulates cortical excitability via cell type-specific tonic inhibition</article-title>
          <source>Nat Neurosci</source>
          <volume>6</volume>
          <year>2003</year>
          <fpage>484</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="pmid">12679782</pub-id>
        </element-citation>
      </ref>
      <ref id="bib45">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Semyanov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Kullmann</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Silver</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>Tonically active GABA A receptors: modulating gain and maintaining the tone</article-title>
          <source>Trends Neurosci</source>
          <volume>27</volume>
          <year>2004</year>
          <fpage>262</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="pmid">15111008</pub-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shekhar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sajdyk</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Gehlert</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Rainnie</surname>
              <given-names>D.G.</given-names>
            </name>
          </person-group>
          <article-title>The amygdala, panic disorder, and cardiovascular responses</article-title>
          <source>Ann N Y Acad Sci</source>
          <volume>985</volume>
          <year>2003</year>
          <fpage>308</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="pmid">12724167</pub-id>
        </element-citation>
      </ref>
      <ref id="bib47">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Lal</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Luellen</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Earnheart</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Luscher</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression</article-title>
          <source>Biol Psychiatry</source>
          <volume>68</volume>
          <year>2010</year>
          <fpage>512</fpage>
          <lpage>520</lpage>
          <pub-id pub-id-type="pmid">20579975</pub-id>
        </element-citation>
      </ref>
      <ref id="bib48">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sieghart</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Sperk</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Subunit composition, distribution and function of GABA(A) receptor subtypes</article-title>
          <source>Curr Top Med Chem</source>
          <volume>2</volume>
          <year>2002</year>
          <fpage>795</fpage>
          <lpage>816</lpage>
          <pub-id pub-id-type="pmid">12171572</pub-id>
        </element-citation>
      </ref>
      <ref id="bib49">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singewald</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping</article-title>
          <source>Neurosci Biobehav Rev</source>
          <volume>31</volume>
          <year>2007</year>
          <fpage>18</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">16620984</pub-id>
        </element-citation>
      </ref>
      <ref id="bib50">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tasan</surname>
              <given-names>R.O.</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>N.K.</given-names>
            </name>
            <name>
              <surname>Weger</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sartori</surname>
              <given-names>S.B.</given-names>
            </name>
            <name>
              <surname>Singewald</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Heilbronn</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Herzog</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sperk</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression</article-title>
          <source>J Neurosci</source>
          <volume>30</volume>
          <year>2010</year>
          <fpage>6282</fpage>
          <lpage>6290</lpage>
          <pub-id pub-id-type="pmid">20445054</pub-id>
        </element-citation>
      </ref>
      <ref id="bib51">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tschenett</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Singewald</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Carli</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Balducci</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Salchner</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Vezzani</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Herzog</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sperk</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors</article-title>
          <source>Eur J Neurosci</source>
          <volume>18</volume>
          <year>2003</year>
          <fpage>143</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="pmid">12859347</pub-id>
        </element-citation>
      </ref>
      <ref id="bib52">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsunashima</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Schwarzer</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kirchmair</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Sieghart</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Sperk</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>GABA(A) receptor subunits in the rat hippocampus III: altered messenger RNA expression in kainic acid-induced epilepsy</article-title>
          <source>Neuroscience</source>
          <volume>80</volume>
          <year>1997</year>
          <fpage>1019</fpage>
          <lpage>1032</lpage>
          <pub-id pub-id-type="pmid">9284057</pub-id>
        </element-citation>
      </ref>
      <ref id="bib53">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ulrich</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bettler</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>GABA(B) receptors: synaptic functions and mechanisms of diversity</article-title>
          <source>Curr Opin Neurobiol</source>
          <volume>17</volume>
          <year>2007</year>
          <fpage>298</fpage>
          <lpage>303</lpage>
          <pub-id pub-id-type="pmid">17433877</pub-id>
        </element-citation>
      </ref>
      <ref id="bib54">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Woodruff</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Monyer</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sah</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>GABAergic excitation in the basolateral amygdala</article-title>
          <source>J Neurosci</source>
          <volume>26</volume>
          <year>2006</year>
          <fpage>11881</fpage>
          <lpage>11887</lpage>
          <pub-id pub-id-type="pmid">17108161</pub-id>
        </element-citation>
      </ref>
      <ref id="bib55">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zarnowska</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Keist</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Rudolph</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Pearce</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <article-title>GABAA receptor alpha5 subunits contribute to GABAA, slow synaptic inhibition in mouse hippocampus</article-title>
          <source>J Neurophysiol</source>
          <volume>101</volume>
          <year>2009</year>
          <fpage>1179</fpage>
          <lpage>1191</lpage>
          <pub-id pub-id-type="pmid">19073796</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors declare that this work was funded by the Austrian Science fund (S10204, G. Sperk; S10202, N. Singewald; P 22830-B18, RO. Tasan). There are no other personal financial holdings of any of the authors that could be perceived as constituting a potential conflict of interest. We thank Elke Kirchmair and Anna Wieselthaler for technical assistance, Prof. Werner Sieghart for providing antibodies and Prof. Heide Hörtnagl for discussion.</p>
    </ack>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Fig. 1</label>
      <caption>
        <p>Expression of GAD67 mRNA in HAB and NAB mice. (A) Film autoradiographs from <italic>in situ</italic> hybridization experiments displaying increased GAD67 mRNA in coronal sections of a HAB mouse brain compared to NAB controls, a higher magnification showing GAD67 mRNA expression in the amygdaloid complex of HAB mice, (B) increased expression of GAD67 mRNA in coronal brain sections of HAB mice, quantified in the BLA, CEA and MEA and (C) in the somatosensory cortex (CXS), hilus of the dentate gyrus (DG) and dentate granule cell layer (GCL), (D) correlation of ROD values of GAD67 mRNA with percentage open arm time in HAB mice and (E) NAB controls. Values in (A) and (B) are means±SEM, one-way ANOVA with Bonferroni <italic>post hoc</italic> test, *** <italic>P</italic>&lt;0.001 (HAB <italic>n</italic>=16, NAB <italic>n</italic>=19); scale bars: 500 μm.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Fig. 2</label>
      <caption>
        <p>GAD67 and GABA immunoreactivity (IR) in the amygdala of HAB and NAB mice. (A) Bright field photomicrographs of representative, matched sections demonstrating GAD67-IR labeling in the amygdala of HAB and NAB mice, higher magnification depicts increased number of GAD67-IR positive cells in the BLA of HAB mice compared to NAB controls, (B) bright field photomicrographs of GABA-IR labeling on representative, matched sections demonstrating an increased number of GABA-IR positive cells in the BLA of HAB mice, (C) quantification of GAD67-IR and GABA-IR positive cells in the BLA of HAB and NAB mice. Arrows in (A) and (B) depict GAD67-IR and GABA-IR positive cells in the BLA of NAB mice, respectively. Values in (C) are means±SEM, Mann–Whitney test, * <italic>P</italic>&lt;0.05; ** <italic>P</italic>&lt;0.01 (HAB <italic>n</italic>=4, NAB <italic>n</italic>=4), scale bars: low magnification 500 μm, high magnification 50 μm.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Fig. 3</label>
      <caption>
        <p>FosB immunoreactivity in the BLA of HAB and NAB mice. (A) High magnification, bright field photomicrograph of representative, matched sections showing FosB positive cells in the BLA of NAB and HAB mice, (B) quantification demonstrating increased number of FosB positive cells in the BLA of HAB mice, (C) dual labeling immunofluorescence reveals colocalization of FosB (green) staining with (red) CaMKII but not with (red) GAD67-IR in the BLA, arrows in (C) show CaMKII positive and GAD67 positive cells, respectively. Values in (B) are means±SEM, Mann–Whitney test, * <italic>P</italic>&lt;0.05 (HAB <italic>n</italic>=4, NAB <italic>n</italic>=4), scale bars: (A) 50 μm, (C) 10 μm. For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Fig. 4</label>
      <caption>
        <p>GABA<sub>A</sub> receptor subunit mRNAs in the amygdala of HAB and NAB mice. (A+B) Film autoradiographs and (C+D) pseudocolor coded images of GABA<sub>A</sub> receptor γ1 subunit mRNA in the amygdala of HAB (B+D) and NAB mice (A+C) are shown, arrows in (B) and (D) indicate reduced expression of γ1 subunit mRNA in the amygdala of a HAB mouse, (E+F) film autoradiographs and (G+H) pseudocolor coded images of an <italic>in situ</italic> hybridization demonstrating increased β2 mRNA in the BLA of HAB mice (F+H) compared to NAB controls (E+G), arrows in (F) and (H) indicate increased expression of β2 mRNA in the BLA of a HAB mouse. Scale bars: (A–D) 500 μm; (E–H) 500 μm. For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>Fig. 5</label>
      <caption>
        <p>Immunoreactivities for GABA<sub>A</sub> receptor β2 and γ2 subunits in the basolateral amygdala (BLA) of HAB and NAB mice. (A) Bright field photomicrographs of representative, matched sections demonstrating β2 subunit-IR labeling and (B) γ2 subunit-IR labeling in the BLA of HAB and NAB mice. Arrows indicate IR in the BLA. Note the increased labeling of the BLA compared to the lateral amygdala (LA) in HAB mice. BMA, basomedial amygdala. Scale bar: 500 μm.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <table-wrap id="tbl1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Oligonucleotide sequence for <italic>in situ</italic> hybridization</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">mRNA</th>
            <th align="left">Access code</th>
            <th align="left">Oligonuceotide sequence</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">α1</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_010250.3">NM_010250.3</ext-link>
            </td>
            <td align="left">5′ CCT GGC TAA GTT AGG GGT ATA GCT GGT TGC TGT AGG AGC ATA TGT 3′</td>
          </tr>
          <tr>
            <td align="left">α2</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_008066.3">NM_008066.3</ext-link>
            </td>
            <td align="left">5′ CAT CGG GAG CAA CCT GAA CGG AGT CAG AAG CAT TGT AAG TCC 3′</td>
          </tr>
          <tr>
            <td align="left">α3</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_008067.3">NM_008067.3</ext-link>
            </td>
            <td align="left">5′ GGC CAG ATT GAT AGG ATA GGT GGT ACC CAC TAT GTT GAA GGT GGT G 3′</td>
          </tr>
          <tr>
            <td align="left">α4</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_010251.2">NM_010251.2</ext-link>
            </td>
            <td align="left">5′ GGA TGT TTC TGT GTG TTT CTC CTT CAG CAC AGG AGC AGC TGG 3′</td>
          </tr>
          <tr>
            <td align="left">α5</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_176942.3">NM_176942.3</ext-link>
            </td>
            <td align="left">5′ TTG GGA TGT TTG GAG GAT GGG TCA GCT TTC CAG TTG T 3′</td>
          </tr>
          <tr>
            <td align="left">β1</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_008069.4">NM_008069.4</ext-link>
            </td>
            <td align="left">5′ TGC CTG TCC AGC CCA CGC CCG AAG CCC TCG CGG CTG CTC AGT GG 3′</td>
          </tr>
          <tr>
            <td align="left">β2</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_008070.3">NM_008070.3</ext-link>
            </td>
            <td align="left">5′ ACT GTT TGA AGA GGA ATC CAG TCC TTG CTT CTC ACG GAA GGC TG 3′</td>
          </tr>
          <tr>
            <td align="left">β3</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_001038701.1">NM_001038701.1</ext-link>
            </td>
            <td align="left">5′ CTG TCT CCC ATG TAC CGC CCA TGC CCT TCC TTG GGC ATG CTC TGT 3′</td>
          </tr>
          <tr>
            <td align="left">γ1</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_010252.4">NM_010252.4</ext-link>
            </td>
            <td align="left">5′ GGG AAT GAG AGT GGA TCC AGC ATG GAG ACC TGG GGA 3′</td>
          </tr>
          <tr>
            <td align="left">γ2</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_008073.2">NM_008073.2</ext-link>
            </td>
            <td align="left">5′ GGC AAT GCG AAT ATG TAT CCT CCC ATG TCT CCA GGC TCC TGT TCG GC 3′</td>
          </tr>
          <tr>
            <td align="left">ə</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_008072.1">NM_008072.1</ext-link>
            </td>
            <td align="left">5′ GGC AAG GTC CAT GTC ACA GGC CAC TGT GGA GGT GAT GCG GAT GCT GTA T 3′</td>
          </tr>
          <tr>
            <td align="left">GAD65</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_008078.2">NM_008078.2</ext-link>
            </td>
            <td align="left">5′ CTC CAT CAC ACG CTG GCA GGT CTG TTG CGT GCA G 3′</td>
          </tr>
          <tr>
            <td align="left">GAD67</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_008077.3">NM_008077.3</ext-link>
            </td>
            <td align="left">5′ GCA GGT TCT TGG AGG ACT GCC TCT CCC TGA AGG CGC TCA C 3′</td>
          </tr>
          <tr>
            <td align="left">GBBR1</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_019439.3">NM_019439.3</ext-link>
            </td>
            <td align="left">5′ AAG CCA CGG TAC CTG ATG CCA CCT TCC CAG GGC GGA TGT ATA ATC TGG C 3′</td>
          </tr>
          <tr>
            <td align="left">GBBR2</td>
            <td align="left">
              <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_001081141.1">NM_001081141.1</ext-link>
            </td>
            <td align="left">5′ GAT GTA TGT GGT CTT CTC TGG TGT GTC TTG TAG CTG CAT GGT GAC TTC TTC C 3′</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="tbl2" position="float" orientation="landscape">
      <?landscape?>
      <?legal?>
      <label>Table 2</label>
      <caption>
        <p>mRNA signals of amygdala nuclei in NAB and HAB mice</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Subregions/strains</th>
            <th align="left">α1</th>
            <th align="left">α2</th>
            <th align="left">α3</th>
            <th align="left">α4</th>
            <th align="left">α5</th>
            <th align="left">β1</th>
            <th align="left">β2</th>
            <th align="left">β3</th>
            <th align="left">γ1</th>
            <th align="left">γ2</th>
            <th align="left">GAD67</th>
            <th align="left">GAD65</th>
            <th align="left">GBBR1</th>
            <th align="left">GBBR2</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">BLA</td>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left"> NAB</td>
            <td align="char">100±3.9</td>
            <td align="char">100±3.2</td>
            <td align="char">100±2.3</td>
            <td align="char">100±3.2</td>
            <td align="char">100±4.2</td>
            <td align="char">100±5.1</td>
            <td align="char">100±4.6</td>
            <td align="char">100±3.1</td>
            <td align="char">100±6.4</td>
            <td align="char">100±3.0</td>
            <td align="char">100±3.3</td>
            <td align="char">100±3.8</td>
            <td align="char">100±7.9</td>
            <td align="char">100±2.7</td>
          </tr>
          <tr>
            <td align="left"> HAB</td>
            <td align="char">95±3.7</td>
            <td align="char">109±4.7</td>
            <td align="char">106±2.5</td>
            <td align="char">105±4.8</td>
            <td align="char">102±7.5</td>
            <td align="char">120±6.0</td>
            <td align="char">129±5.9</td>
            <td align="char">96±4.8</td>
            <td align="char">74±7.2</td>
            <td align="char">115±4.4</td>
            <td align="char">135±5.0</td>
            <td align="char">126±5.1</td>
            <td align="char">106±3.3</td>
            <td align="char">94±5.9</td>
          </tr>
          <tr>
            <td align="left"> <italic>P</italic>-value</td>
            <td align="char">0.340</td>
            <td align="char">0.134</td>
            <td align="char">0.081</td>
            <td align="char">0.387</td>
            <td align="char">0.783</td>
            <td align="char">
              <bold>0.015</bold>
            </td>
            <td align="char">
              <bold>0.</bold>
              <ext-link ext-link-type="uri" xlink:href="mi:0005">
                <bold>0005</bold>
              </ext-link>
            </td>
            <td align="char">0.483</td>
            <td align="char">
              <bold>0.009</bold>
            </td>
            <td align="char">
              <bold>0.007</bold>
            </td>
            <td align="char">
              <bold>&lt;0.</bold>
              <ext-link ext-link-type="uri" xlink:href="mi:0001">
                <bold>0001</bold>
              </ext-link>
            </td>
            <td align="char">
              <bold>0.</bold>
              <ext-link ext-link-type="uri" xlink:href="mi:0002">
                <bold>0002</bold>
              </ext-link>
            </td>
            <td align="char">0.491</td>
            <td align="char">0.357</td>
          </tr>
          <tr>
            <td align="left">CEA</td>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left"> NAB</td>
            <td align="char">100±4.9</td>
            <td align="char">100±2.2</td>
            <td align="char">100±3.7</td>
            <td align="char">100±6.3</td>
            <td align="char">100±2.4</td>
            <td align="char">100±5.7</td>
            <td align="char">100±5.8</td>
            <td align="char">100±3.4</td>
            <td align="char">100±4.7</td>
            <td align="char">100±5.0</td>
            <td align="char">100±4.2</td>
            <td align="char">100±3.2</td>
            <td align="char">100±7.8</td>
            <td align="char">100±4.8</td>
          </tr>
          <tr>
            <td align="left"> HAB</td>
            <td align="char">92±4.8</td>
            <td align="char">108±3.4</td>
            <td align="char">106±2.9</td>
            <td align="char">113±8.7</td>
            <td align="char">74±2.4</td>
            <td align="char">118±5.7</td>
            <td align="char">115±5.6</td>
            <td align="char">97±5.1</td>
            <td align="char">75±5.7</td>
            <td align="char">118±7.6</td>
            <td align="char">124±4.3</td>
            <td align="char">121±2.7</td>
            <td align="char">107±4.2</td>
            <td align="char">90±3.6</td>
          </tr>
          <tr>
            <td align="left"> <italic>P</italic>-value</td>
            <td align="char">0.267</td>
            <td align="char">
              <bold>0.047</bold>
            </td>
            <td align="char">0.229</td>
            <td align="char">0.237</td>
            <td align="char">
              <bold>&lt;0.</bold>
              <ext-link ext-link-type="uri" xlink:href="mi:0001">
                <bold>0001</bold>
              </ext-link>
            </td>
            <td align="char">
              <bold>0.032</bold>
            </td>
            <td align="char">0.083</td>
            <td align="char">0.670</td>
            <td align="char">
              <bold>0.002</bold>
            </td>
            <td align="char">
              <bold>0.046</bold>
            </td>
            <td align="char">
              <bold>0.</bold>
              <ext-link ext-link-type="uri" xlink:href="mi:0004">
                <bold>0004</bold>
              </ext-link>
            </td>
            <td align="char">
              <bold>&lt;0.</bold>
              <ext-link ext-link-type="uri" xlink:href="mi:0001">
                <bold>0001</bold>
              </ext-link>
            </td>
            <td align="char">0.433</td>
            <td align="char">0.139</td>
          </tr>
          <tr>
            <td align="left">MEA</td>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left"> NAB</td>
            <td align="char">100±4.8</td>
            <td align="char">100±3.4</td>
            <td align="char">100±3.5</td>
            <td align="char">100±6.6</td>
            <td align="char">100±2.5</td>
            <td align="char">100±5.4</td>
            <td align="char">100±5.8</td>
            <td align="char">100±3.8</td>
            <td align="char">100±5.7</td>
            <td align="char">100±2.7</td>
            <td align="char">100±5.0</td>
            <td align="char">100±4.5</td>
            <td align="char">100±8.4</td>
            <td align="char">100±3.3</td>
          </tr>
          <tr>
            <td align="left"> HAB</td>
            <td align="char">91±3.1</td>
            <td align="char">107±4.6</td>
            <td align="char">104±2.7</td>
            <td align="char">112±6.9</td>
            <td align="char">78±3.5</td>
            <td align="char">120±5.5</td>
            <td align="char">114±6.2</td>
            <td align="char">97±5.5</td>
            <td align="char">82±5.3</td>
            <td align="char">103±7.0</td>
            <td align="char">127±5.3</td>
            <td align="char">123±3.0</td>
            <td align="char">109±3.4</td>
            <td align="char">94±5.4</td>
          </tr>
          <tr>
            <td align="left"> <italic>P</italic>-value</td>
            <td align="char">0.135</td>
            <td align="char">0.257</td>
            <td align="char">0.395</td>
            <td align="char">0.255</td>
            <td align="char">
              <bold>&lt;0.</bold>
              <ext-link ext-link-type="uri" xlink:href="mi:0001">
                <bold>0001</bold>
              </ext-link>
            </td>
            <td align="char">
              <bold>0.013</bold>
            </td>
            <td align="char">0.115</td>
            <td align="char">0.603</td>
            <td align="char">
              <bold>0.024</bold>
            </td>
            <td align="char">0.397</td>
            <td align="char">
              <bold>0.</bold>
              <ext-link ext-link-type="uri" xlink:href="mi:0007">
                <bold>0007</bold>
              </ext-link>
            </td>
            <td align="char">
              <bold>0.</bold>
              <ext-link ext-link-type="uri" xlink:href="mi:0003">
                <bold>0003</bold>
              </ext-link>
            </td>
            <td align="char">0.369</td>
            <td align="char">0.360</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>Data are mean±SEM of % of NAB. Numbers of animals: NAB, <italic>n</italic>=19; HAB, <italic>n</italic>=16.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>